BAG-1 interacts with the p50–p50 homodimeric NF-?B complex: implications for colorectal carcinogenesis
BAG-1 interacts with the p50–p50 homodimeric NF-?B complex: implications for colorectal carcinogenesis
Understanding the mechanisms that promote aberrant tumour cell survival is critical for the determination of novel strategies to combat colorectal cancer (CRC). We have recently shown that the anti-apoptotic protein BAG-1, highly expressed in pre-malignant and CRC tissue, can potentiate cell survival through regulating NF-?B transcriptional activity. In this study, we identify a novel complex between BAG-1 and the p50–p50 NF-?B homodimers, implicating BAG-1 as a co-regulator of an atypical NF-?B pathway. Importantly, the BAG-1-p50 complex was detected at gene regulatory sequences including the epidermal growth factor receptor (EGFR) and COX-2 (PTGS2) genes. Suppression of BAG-1 expression using small interfering RNA was shown to increase EGFR and suppress COX-2 expression in CRC cells. Furthermore, mouse embryonic fibroblasts derived from the NF-?B1 (p105/p50) knock-out mouse were used to demonstrate that p50 expression was required for BAG-1 to suppress EGFR expression. This was shown to be functionally relevant as attenuation of BAG-1 expression increased ligand activated phosphorylation of EGFR in CRC cells. In summary, this paper identifies a novel role for BAG-1 in modulating gene expression through interaction with the p50–p50 NF-?B complexes. Data presented led us to propose that BAG-1 can act as a selective regulator of p50–p50 NF-?B responsive genes in colorectal tumour cells, potentially important for the promotion of cell survival in the context of the fluctuating tumour microenvironment. As BAG-1 expression is increased in the developing adenoma through to metastatic lesions, understanding the function of the BAG-1-p50 NF-?B complexes may aid in identifying strategies for both the prevention and treatment of CRC.
2761-2772
Southern, S.L.
f51cb8c0-ba68-454a-9e00-56b158aa0266
Collard, T. J.
0a5689bb-874b-40dc-81ad-0bcb3b7b503b
Urban, B. C.
27695e24-5504-4181-bc78-338e7aa05a6d
Skeen, V. R.
a49c699d-8b63-43a2-b757-db073f0bbf06
Smartt, H. J.
87f9be4a-5608-4f76-a5e8-206cc1686bee
Hague, A.
ea2f8822-0c83-4868-a7f0-91e35371e636
Oakley, F.
f226e690-1d98-4604-9add-f1c4c2721f5d
Townsend, P. A.
61c2084e-4fb2-4e8e-948a-1f51ba438948
Perkins, N. D.
cd0fd1b8-1a84-45d3-aef1-6cee63249309
Paraskeva, C.
efc0747a-0937-46a3-9929-39a20ea6c28b
Williams, A. C.
637ae774-233e-4913-8cba-358dfabd34aa
31 May 2012
Southern, S.L.
f51cb8c0-ba68-454a-9e00-56b158aa0266
Collard, T. J.
0a5689bb-874b-40dc-81ad-0bcb3b7b503b
Urban, B. C.
27695e24-5504-4181-bc78-338e7aa05a6d
Skeen, V. R.
a49c699d-8b63-43a2-b757-db073f0bbf06
Smartt, H. J.
87f9be4a-5608-4f76-a5e8-206cc1686bee
Hague, A.
ea2f8822-0c83-4868-a7f0-91e35371e636
Oakley, F.
f226e690-1d98-4604-9add-f1c4c2721f5d
Townsend, P. A.
61c2084e-4fb2-4e8e-948a-1f51ba438948
Perkins, N. D.
cd0fd1b8-1a84-45d3-aef1-6cee63249309
Paraskeva, C.
efc0747a-0937-46a3-9929-39a20ea6c28b
Williams, A. C.
637ae774-233e-4913-8cba-358dfabd34aa
Southern, S.L., Collard, T. J., Urban, B. C., Skeen, V. R., Smartt, H. J., Hague, A., Oakley, F., Townsend, P. A., Perkins, N. D., Paraskeva, C. and Williams, A. C.
(2012)
BAG-1 interacts with the p50–p50 homodimeric NF-?B complex: implications for colorectal carcinogenesis.
Oncogene, 31 (22), .
(doi:10.1038/onc.2011.452).
Abstract
Understanding the mechanisms that promote aberrant tumour cell survival is critical for the determination of novel strategies to combat colorectal cancer (CRC). We have recently shown that the anti-apoptotic protein BAG-1, highly expressed in pre-malignant and CRC tissue, can potentiate cell survival through regulating NF-?B transcriptional activity. In this study, we identify a novel complex between BAG-1 and the p50–p50 NF-?B homodimers, implicating BAG-1 as a co-regulator of an atypical NF-?B pathway. Importantly, the BAG-1-p50 complex was detected at gene regulatory sequences including the epidermal growth factor receptor (EGFR) and COX-2 (PTGS2) genes. Suppression of BAG-1 expression using small interfering RNA was shown to increase EGFR and suppress COX-2 expression in CRC cells. Furthermore, mouse embryonic fibroblasts derived from the NF-?B1 (p105/p50) knock-out mouse were used to demonstrate that p50 expression was required for BAG-1 to suppress EGFR expression. This was shown to be functionally relevant as attenuation of BAG-1 expression increased ligand activated phosphorylation of EGFR in CRC cells. In summary, this paper identifies a novel role for BAG-1 in modulating gene expression through interaction with the p50–p50 NF-?B complexes. Data presented led us to propose that BAG-1 can act as a selective regulator of p50–p50 NF-?B responsive genes in colorectal tumour cells, potentially important for the promotion of cell survival in the context of the fluctuating tumour microenvironment. As BAG-1 expression is increased in the developing adenoma through to metastatic lesions, understanding the function of the BAG-1-p50 NF-?B complexes may aid in identifying strategies for both the prevention and treatment of CRC.
This record has no associated files available for download.
More information
Accepted/In Press date: 3 October 2011
Published date: 31 May 2012
Organisations:
Cancer Sciences
Identifiers
Local EPrints ID: 202467
URI: http://eprints.soton.ac.uk/id/eprint/202467
ISSN: 0950-9232
PURE UUID: 7a3de64a-f821-45fd-a36c-6ee7d7b4a93d
Catalogue record
Date deposited: 08 Nov 2011 15:05
Last modified: 14 Mar 2024 04:24
Export record
Altmetrics
Contributors
Author:
S.L. Southern
Author:
T. J. Collard
Author:
B. C. Urban
Author:
V. R. Skeen
Author:
H. J. Smartt
Author:
A. Hague
Author:
F. Oakley
Author:
P. A. Townsend
Author:
N. D. Perkins
Author:
C. Paraskeva
Author:
A. C. Williams
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics